Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

alglucosidase alfa 50 MG Injection [Myozyme]

Known as: ALGLUCOSIDASE ALFA 5 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Myozyme], Myozyme 50 MG Injection 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Der Morbus (M.) Pompe ist durch nächtliche Hypoventilation gekennzeichnet, erklärte Prof. Dr. Peter Young, Schlafmediziner von… Expand
2017
2017
Der Morbus (M.) Pompe ist durch nächtliche Hypoventilation gekennzeichnet, erklärte Prof. Dr. Peter Young, Schlafmediziner von… Expand
2017
2017
Der Morbus (M.) Pompe ist durch nächtliche Hypoventilation gekennzeichnet, erklärte Prof. Dr. Peter Young, Schlafmediziner von… Expand
Review
2016
Review
2016
Pompe disease (PD) is a potentially lethal illness involving irreversible muscle damage resulting from glycogen storage in muscle… Expand
  • table 1
  • table 3
  • table 5
  • table 6
  • table 7
2011
2011
We examined the efficacy of 2-year enzyme replacement therapy (ERT) using recombinant human α-glucosidase (GAA; Myozyme®) in five… Expand
2011
2011
Malaltia de Pompe; Alglucosidasa alfa; Glicogenosi tipus II; Pompe disease; Alglucosidase alpha; Glycogenosis type II; Enfermedad… Expand
2007
2007
Resume Les myopathies metaboliques forment un groupe de myopathies caracterisees par un defaut inne du metabolisme intermediaire… Expand